Skip to main navigation Skip to search Skip to main content

18F-FDG PET/CT in detection of gynecomastia in patients with hepatocellular carcinoma

  • Hsin Yi Wang
  • , Long Bin Jeng
  • , Ming Chia Lin
  • , Chih Hao Chao
  • , Wan Yu Lin
  • , Chia Hung Kao*
  • *Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

8 Scopus citations

Abstract

Objective: We retrospectively investigate the prevalence of gynecomastia as false-positive 2-[18F]fluoro-2-deoxy-d-glucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT) imaging in patients with hepatocellular carcinoma (HCC). Methods: Among the 127 male HCC patients who underwent 18F-FDG PET/CT scan, the 18FDG uptakes at the bilateral breasts in 9 patients with gynecomastia were recorded as standard uptake value (SUVmax) and the visual interpretation in both early and delayed images. Results: The mean early SUVmax was 1.58/1.57 (right/left breast) in nine gynecomastia patients. The three patients with early visual score of 3 had higher early SUVmaxs. Conclusion: Gynecomastia is a possible cause of false-positive uptake on 18F-FDG PET/CT images.

Original languageEnglish
Pages (from-to)942-946
Number of pages5
JournalClinical Imaging
Volume37
Issue number5
DOIs
StatePublished - 09 2013
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • FDG PET/CT
  • Gynecomastia
  • Hepatocellular carcinoma
  • SUVmax

Fingerprint

Dive into the research topics of '18F-FDG PET/CT in detection of gynecomastia in patients with hepatocellular carcinoma'. Together they form a unique fingerprint.

Cite this